A New Generation of Drugs Could Lower Heart Attack Risk for Millions

P.M. Edition for May 27. Pharmaceutical companies have been testing a new type of drug to lower levels of lipoprotein(a); high levels have been linked to heart disease and can’t be lowered with diet and exercise. WSJ reporter Xavier Martinez walks us through how the new drugs work and what is still needed before they can make their way to patients. Plus, Ford’s stock has been surging for the past two weeks, but the reason doesn’t have much to do with cars. Journal autos reporter Ryan Felton discusses. And President Trump says he doesn’t fear political fallout from the Iran war, while the U.S. blockade throttles the Iranian economy. We hear from WSJ Middle East correspondent Benoit Faucon about what that economic pressure means for both sides as they seek a deal for long-term peace. Alex Ossola hosts.

Sign up for the WSJ's free What's News newsletter.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.